Summary
No FDA-approved prescribing information text/sections were provided, so none of the extracted claims can be verified against the label. A label-safety alignment assessment (contraindications, warnings, dosing/administration, monitoring, adverse reactions, interactions, and specific populations) could not be performed.
Category Scores
Accurate Statements
Unsupported Statements
Triamterene is commonly available in 37.5 mg strengths.
Cannot be supported or refuted because no FDA label text/sections were provided.
Triamterene is commonly available in 75 mg strengths.
Cannot be supported or refuted because no FDA label text/sections were provided.
Prescription prices for triamterene can range from approximately $10 to over $50 for a 30-day supply depending on the pharmacy and insurance coverage.
Cannot be supported or refuted because no FDA label text/sections were provided.
Generic versions of triamterene are generally less expensive than brand-name options.
Cannot be supported or refuted because no FDA label text/sections were provided.
A 30-day supply of 75 mg capsules can cost around $15 to $30 without insurance at some pharmacies.
Cannot be supported or refuted because no FDA label text/sections were provided.
A 30-day supply of 75 mg capsules can cost as low as $5 to $10 with discount programs.
Cannot be supported or refuted because no FDA label text/sections were provided.
Many pharmacies offer discount cards or coupons that can reduce the out-of-pocket cost of medications.
Cannot be supported or refuted because no FDA label text/sections were provided.
Comparing prices across different online pharmacies can reveal significant savings.
Cannot be supported or refuted because no FDA label text/sections were provided.
Opting for generic triamterene, when available, is a common strategy to lower costs.
Cannot be supported or refuted because no FDA label text/sections were provided.
Having prescription drug insurance can substantially lower the price.
Cannot be supported or refuted because no FDA label text/sections were provided.
Copays can be much less than the retail price.
Cannot be supported or refuted because no FDA label text/sections were provided.
Without insurance, the cash price for triamterene can be higher.
Cannot be supported or refuted because no FDA label text/sections were provided.
A 30-day supply of triamterene capsules (e.g., 75 mg) might cost between $10 and $50 or more depending on the specific pharmacy and the number of pills in the prescription.
Cannot be supported or refuted because no FDA label text/sections were provided.
Prices can differ between triamterene strengths.
Cannot be supported or refuted because no FDA label text/sections were provided.
A prescription for triamterene 37.5 mg might be priced differently than a prescription for triamterene 75 mg.
Cannot be supported or refuted because no FDA label text/sections were provided.
Combination products such as triamterene/hydrochlorothiazide have different pricing structures compared to triamterene alone.
Cannot be supported or refuted because no FDA label text/sections were provided.
Triamterene is an older drug with patents that have long since expired.
Cannot be supported or refuted because no FDA label text/sections were provided.
Triamterene is available as a generic medication.
Cannot be supported or refuted because no FDA label text/sections were provided.
The lack of patent protection allows multiple manufacturers to produce and sell triamterene.
Cannot be supported or refuted because no FDA label text/sections were provided.
Multiple manufacturers contributing to competitive pricing affects the drug's price.
Cannot be supported or refuted because no FDA label text/sections were provided.
Several pharmaceutical companies manufacture generic versions of triamterene.
Cannot be supported or refuted because no FDA label text/sections were provided.
Teva Pharmaceuticals manufactures generic versions of triamterene.
Cannot be supported or refuted because no FDA label text/sections were provided.
Sandoz manufactures generic versions of triamterene.
Cannot be supported or refuted because no FDA label text/sections were provided.
Mylan manufactures generic versions of triamterene.
Cannot be supported or refuted because no FDA label text/sections were provided.
The availability of multiple generic manufacturers helps to keep prices competitive.
Cannot be supported or refuted because no FDA label text/sections were provided.
Contradictions
Important Omissions
FDA-label safety and prescribing elements were not evaluable because no FDA-approved prescribing information text/sections were provided (e.g., boxed warnings, contraindications, warnings/precautions, dosage & administration, monitoring recommendations, drug interactions, adverse reactions, and use in specific populations).
Importance:
High
Safety Assessment
Potential Patient Risk:
High
Because no FDA label content was provided, the audit cannot verify that the AI response includes or omits critical safety-related prescribing information. This prevents a label-based safety alignment assessment.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Verifiable
Primary Issue
No FDA-approved prescribing information sections/text were provided, so no claim-to-label verification is possible and safety-label alignment cannot be assessed.
Suggested Improvement
Provide the full FDA-approved prescribing information (label text/sections) for triamterene so each extracted claim can be checked for support, contradictions, and material omissions (especially dosing/administration, contraindications, boxed warnings, warnings/precautions, monitoring, interactions, adverse reactions, and special populations).